Investigation of the safety and efficacy of Epolyrec on ESRD patients on hemodialysis and comparison with EPREX

Trial Profile

Investigation of the safety and efficacy of Epolyrec on ESRD patients on hemodialysis and comparison with EPREX

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Erythropoietin (Primary)
  • Indications Renal failure
  • Focus Therapeutic Use
  • Sponsors Notarkib Recpharma Biopharmaceuticals
  • Most Recent Events

    • 19 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top